When to Screen in Obstetrics and Gynecology

When to Screen in Obstetrics and Gynecology is a resource designed to assist obstetricians and gynecologists, midwives, and family practitioners in making some complex decisions regarding screening tests by providing the following considerations: what is the problem that requires screening; the tests; and conclusions and recommendations.


Features

-Easy-to-read format Helps practitioner make everyday decisions quickly -International author group Considers how cost of testing and frequency of disorder varies among locations -Templated format discusses: problem that requires screening; the actual tests; conclusions and recommendations; and summary Facilitates rapid identification of information -Addresses reliability and validity of tests With patients armed with large amounts of incomplete information, this allows physician to better determine which tests are truly necessary -Offers a Q&A summary at the end of each chapter -Reviews and refreshes salient material -Discusses purpose of test, implications conclusions and recommendations Helps physician clarify difference between screening and actual diagnosis
Back to top

What's New

New screening information on cholesterol levels, depression and hypertension
Back to top

Contents

1 Epidemiologic Considerations in Screening 2 Maternal Red Blood Cell Group and Antibody Screen 3 Antepartum Assessment of Hemoglobin, Hematocrit, and Serum Ferritin 4 Postpartum Assessment of Hemoglobin, Hematocrit, and Serum Ferritin 5 Asymptomatic Bacteriuria in Pregnancy 6 Neonatal Group B Streptococcal Disease 7 Rubella During Pregnancy 8 Congenital Toxoplasmosis 9 Congenital Cytomegalovirus Infection 10 Hepatitis A, B, and C During Pregnancy 11 Syphilis 12 Gonorrhea 13 Chlamydial Infection 14 HIV Infection 15 Screening for Cystic Fibrosis Carrier Status 16 Screening for Hemoglobinopathies 17 Early-onset Genetic Disease 18 Screening for Fragile X Syndrome 19 Screening for Huntington Disease 20 Routine Ultrasound for Dating 21 First Trimester Screening for Aneuploidy 22 Second Trimester Screening for Aneuploidy (Ultrasound and Biochemistry) 23 Biochemical Screening for Fetal Abnormalities 24 Routine Ultrasonography for the Detection of Fetal Structural Anomalies 25 Molecular Tests for Antenatal Detection of Aneuploidy 26 Thrombophilia and Pregnancy Complications: Preeclampsia, (Late) Intrauterine Fetal Death, and Thrombosis 27 Screening for Autoimmune Diseases in Pregnancy 28 Gestational Diabetes Mellitus 29 Screening for Low Birth Weight Using Maternal Height and Weight 30 Fundal Height Measurement 31 Fetal Growth Restriction 32 Doppler Velocimetry for the Detection of Intrauterine Growth Restriction 33 Preterm Delivery 34 Preeclampsia: Blood Pressure, Weight Gain, and Edema 35 Uterine Artery Doppler as Screening Tool for Preeclampsia 36 Preeclampsia and Uric Acid 37 Fetal Hypoxia 38 Peripartum Coagulopathy 39 Postpartum Umbilical Cord Blood Testing 40 When to Screen for Neonatal Hypoglycemia 41 Neonatal Hyperbilirubinemia 42 Screening for Neonatal Genetic Disorders 43 The Annual Bimanual Examination 44 Dyslipidemia 45 Diabetes Mellitus 46 Screening Tests for Contraceptive Users 47 Genetic Predisposition to Gynecologic Cancers 48 Screening for Breast Cancer 49 Pap Smear 50 High-Risk Human Papillomavirus Testing in Cervical Cancer Screening 51 Transvaginal Ultrasound as a Screening Method for Ovarian Cancer 52 Serum CA-125 Screening for Ovarian Cancer 53 Screening for Colorectal Cancer 54 The Electrocardiogram 55 Intravenous Pyleography 56 Osteoporosis Index